| scholarly article | Q13442814 |
| P2093 | author name string | J J Sung | |
| L I Gold | |||
| M T Longaker | |||
| J W Siebert | |||
| P2860 | cites work | The soluble exoplasmic domain of the type II transforming growth factor (TGF)-beta receptor. A heterogeneously glycosylated protein with high affinity and selectivity for TGF-beta ligands | Q24313061 |
| Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity | Q24317253 | ||
| Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors | Q24319747 | ||
| Receptors for the TGF-β family | Q28210923 | ||
| Transforming growth factor beta in tissue fibrosis | Q28239292 | ||
| Mechanism of activation of the TGF-beta receptor | Q28245861 | ||
| Characterization of type I receptors for transforming growth factor-beta and activin | Q28251169 | ||
| Determination of type I receptor specificity by the type II receptors for TGF-beta or activin | Q28256128 | ||
| Expression cloning and characterization of the TGF-beta type III receptor | Q28304515 | ||
| Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor | Q28507865 | ||
| A transforming growth factor beta type I receptor that signals to activate gene expression | Q28576285 | ||
| Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor | Q28631183 | ||
| Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation | Q33583459 | ||
| The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms | Q34349039 | ||
| Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair | Q34437758 | ||
| Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor beta receptor kinases | Q34632777 | ||
| Transforming growth factor beta (TGF-?) in inflammation: A cause and a cure | Q35226955 | ||
| Transforming growth factor-beta: recent progress and new challenges | Q35236115 | ||
| Transforming growth factor-beta in disease: the dark side of tissue repair | Q35603155 | ||
| TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors | Q36235100 | ||
| Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta | Q36352371 | ||
| Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development | Q36532922 | ||
| Transforming growth factor beta increases cell surface binding and assembly of exogenous (plasma) fibronectin by normal human fibroblasts | Q36846912 | ||
| Transforming growth factor beta 1, a potent chemoattractant for human neutrophils, bypasses classic signal-transduction pathways. | Q37567229 | ||
| Wound repair in the context of extracellular matrix | Q40396964 | ||
| The role of extracellular matrix in postinflammatory wound healing and fibrosis | Q40694808 | ||
| Transforming growth factor-beta: latent forms, binding proteins and receptors | Q40851998 | ||
| Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). | Q40883581 | ||
| A human Mad protein acting as a BMP-regulated transcriptional activator | Q41192122 | ||
| Betaglycan presents ligand to the TGF beta signaling receptor. | Q41542611 | ||
| Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities. | Q41552765 | ||
| Release of transforming growth factor-beta 1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin | Q41589853 | ||
| Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase | Q41639273 | ||
| Distinct transforming growth factor-beta (TGF-beta) receptor subsets as determinants of cellular responsiveness to three TGF-beta isoforms. | Q41714420 | ||
| Spatial and temporal patterns of immunoreactive transforming growth factor beta 1, beta 2, and beta 3 during excisional wound repair. | Q42098930 | ||
| Direct evidence for spatial and temporal regulation of transforming growth factor beta 1 expression during cutaneous wound healing | Q42472893 | ||
| Expression of type II transforming growth factor-beta receptor mRNA in human skin, as revealed by in situ hybridization | Q42492508 | ||
| Neutrophil chemotaxis in response to TGF-beta isoforms (TGF-beta 1, TGF-beta 2, TGF-beta 3) is mediated by fibronectin | Q42498936 | ||
| Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair | Q42755598 | ||
| Transforming growth factor-beta 1 modulates beta 1 and beta 5 integrin receptors and induces the de novo expression of the alpha v beta 6 heterodimer in normal human keratinocytes: implications for wound healing. | Q42771319 | ||
| Binding of transforming growth factor-beta to cell surface proteins varies with cell type | Q43778425 | ||
| Regulation of cell adhesion receptors by transforming growth factor-beta. Concomitant regulation of integrins that share a common beta 1 subunit | Q43918850 | ||
| Recombinant human transforming growth factor-beta 1 (rhTGF-beta 1) enhances healing and strength of granulation skin wounds | Q44120022 | ||
| Antagonistic effects of TGF-beta 1 and MSF on fibroblast migration and hyaluronic acid synthesis. Possible implications for dermal wound healing | Q44255126 | ||
| Increased expression of transforming growth factor beta isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action | Q58436671 | ||
| Type I transforming growth factor-beta receptors on neutrophils mediate chemotaxis to transforming growth factor-beta | Q68251070 | ||
| Transforming growth factor beta regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts | Q68520119 | ||
| Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin. I. Excisional wound model | Q68907259 | ||
| Absence of TGF-beta receptors and growth inhibitory responses in retinoblastoma cells | Q69915851 | ||
| Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin: incisional wound model | Q70199915 | ||
| Transforming growth factor-beta induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase | Q70370463 | ||
| Expression of transforming growth factor-beta isoforms in human glomerular diseases | Q71568697 | ||
| Increased expression of transforming growth factor beta isoforms (beta 1, beta 2, beta 3) in bleomycin-induced pulmonary fibrosis | Q71699580 | ||
| Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring | Q71702949 | ||
| Expression of transforming growth factor-beta mRNAs and proteins in pulmonary vascular remodeling in the sheep air embolization model of pulmonary hypertension | Q72031028 | ||
| Injury induced expression of TGF-beta 1 mRNA is enhanced by exogenously applied TGF-beta S | Q72837704 | ||
| Receptors for the TGF-beta superfamily: multiple polypeptides and serine/threonine kinases | Q75292788 | ||
| The TGF-beta family and its composite receptors | Q75293083 | ||
| Spatial and temporal expression of transforming growth factor-beta isoforms during ovine excisional and incisional wound repair | Q79437334 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 209-222 | |
| P577 | publication date | 1997-01-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Type I (RI) and type II (RII) receptors for transforming growth factor-beta isoforms are expressed subsequent to transforming growth factor-beta ligands during excisional wound repair | |
| P478 | volume | 150 |
| Q41986545 | Bisphosphonate-associated osteonecrosis of the jaw is linked to suppressed TGFβ1-signaling and increased Galectin-3 expression: a histological study on biopsies |
| Q35764985 | Cellular retinol-binding protein-1 is transiently expressed in granulation tissue fibroblasts and differentially expressed in fibroblasts cultured from different organs. |
| Q38029833 | Effects of growth factors on dental stem/progenitor cells |
| Q35763720 | Enhanced expression of transforming growth factor-beta type I and type II receptors in wound granulation tissue and hypertrophic scar |
| Q74506491 | Expression of transforming growth factor-beta isoforms and their receptors in chronic tendinosis |
| Q48494769 | Expression of transforming growth factor-beta receptors in meningeal fibroblasts of the injured mouse brain |
| Q42590404 | Interleukin (IL)-6 modulates transforming growth factor-beta expression in skin and dermal fibroblasts from IL-6-deficient mice |
| Q33323350 | Localization of TGF-beta type II receptor and ED-A fibronectin in normal conjunctiva and failed filtering blebs. |
| Q35843286 | Ontogenetic transition in fetal wound transforming growth factor-beta regulation correlates with collagen organization |
| Q35534311 | Regulation of the effects of TGF-beta 1 by activation of latent TGF-beta 1 and differential expression of TGF-beta receptors (T beta R-I and T beta R-II) in idiopathic pulmonary fibrosis |
| Q33855677 | Suppressed Gastric Mucosal TGF-beta1 Increases Susceptibility to H. pylori-Induced Gastric Inflammation and Ulceration: A Stupid Host Defense Response |
| Q42724917 | The Role of TGFβ Signaling in Wound Epithelialization |
Search more.